EXHIBIT 10.31 LICENSE AGREEMENT THIS LICENSE AGREEMENT (the "Agreement") is made and entered into as of July 17, 2001 (the "Effective Date") by and between EXELIXIS, INC., a Delaware corporation having its principal place of business at 170 Harbor...License Agreement • November 14th, 2001 • Exelixis Inc • Services-commercial physical & biological research • New York
Contract Type FiledNovember 14th, 2001 Company Industry Jurisdiction
EXCLUSIVE)License Agreement • March 28th, 2000 • Avant Immunotherapeutics Inc • In vitro & in vivo diagnostic substances • Massachusetts
Contract Type FiledMarch 28th, 2000 Company Industry Jurisdiction
Exclusive License Agreement for Selected Applications of Coated Nanocrystalline ParticlesLicense Agreement • March 24th, 2000 • Biosante Pharmaceuticals Inc • Biological products, (no disgnostic substances) • California
Contract Type FiledMarch 24th, 2000 Company Industry Jurisdiction
Exclusive License Agreement for Selected Applications of Coated Nanocrystalline ParticlesLicense Agreement • February 24th, 2000 • Biosante Pharmaceuticals Inc • Biological products, (no disgnostic substances) • California
Contract Type FiledFebruary 24th, 2000 Company Industry Jurisdiction
Exclusive License Agreement for Selected Applications of Coated Nanocrystalline ParticlesLicense Agreement • December 23rd, 1999 • Ben Abraham Technologies Inc • California
Contract Type FiledDecember 23rd, 1999 Company Jurisdiction
LICENSE AGREEMENTLicense Agreement • February 27th, 1998 • Alliance Pharmaceutical Corp • In vitro & in vivo diagnostic substances • New York
Contract Type FiledFebruary 27th, 1998 Company Industry Jurisdiction
LICENSE AGREEMENTLicense Agreement • December 6th, 1996 • Amerigon Inc • Services-commercial physical & biological research • California
Contract Type FiledDecember 6th, 1996 Company Industry Jurisdiction